The Relationship Between Fibromyalgia Syndrome Parameters With Disease Severity, Pain and the Quality Of Life
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Fibromyalgia Syndrome
- Sponsor
- Umraniye Education and Research Hospital
- Enrollment
- 130
- Locations
- 1
- Primary Endpoint
- Symptom Severity Score
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
In this study, the investigators aim to evaluate the relationship between disease severity, quality of life, anxiety and pain level in patients diagnosed with Fibromyalgia Syndrome (FMS) with the parameters according to the American College of Rheumatology (ACR) 2016 diagnostic criteria. According to the 2016 ACR diagnostic criteria, there are 2 separate scales: Widespread Pain Index (WPI) and Symptom Severity (SS) . The relationship between these 2 parameters and the Fibromyalgia Impact Questionnaire, the World Health Organization Short Quality of Life Questionnaire, and the McGill Melzack Pain Questionnaire and Beck Anxiety Questionnaire will be examined.
Detailed Description
The aim of this study is to observe the relationship between the WPI and SS parameters in the ACR 2016 criteria for fibromyalgia, separately, with the severity of the disease, pain level, quality of life and anxiety level. Accordingly, the investigators aim to evaluate whether WPI or SS has priority in assessing the severity of the disease. There is no study in the literature comparing the importance of the 2016 ACR diagnostic parameters on the disease effect. In this context, this study will be the first study in the literature and will be very valuable. Patients visiting the outpatient clinic with FMS diagnosis will be evaluated. Patients will be asked to fill the World Health Organization Short Quality of Life Questionnaire, and the McGill Melzack Pain Questionnaire and Beck Anxiety Questionnaire . The patients will be assed by an experienced Physical Medicine and Rehabilitation specialist for SS and WPI scores.
Investigators
Özlem Kaleoğlu, MD
Principle Investigator
Umraniye Education and Research Hospital
Eligibility Criteria
Inclusion Criteria
- •Diagnosed as FMS according to ACR 2016 criterias
Exclusion Criteria
- •History of Malignity
- •History of Rheumatological Disease
Outcomes
Primary Outcomes
Symptom Severity Score
Time Frame: at the start of the study
Symptom Severity Score. Ranging from 0-12. Higher scores mean higher symptom scores.
Widespread Pain Index Score
Time Frame: at the start of the study
Widespread Pain Index Score, Ranging from 0-19. Higher scores mean higher pain scores.
Secondary Outcomes
- Beck Anxiety Score(at the start of the study)
- WHO Short Quality of Life Score(at the start of the study)